Pola-R2 in Newly Diagnosed Non-fit Elderly DLBCL Patients

Clinical trial NCT06176729 · RECRUITING

Trial details

NCT number: NCT06176729
Sponsor: Yan Zhang, MD
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma

Start date: 2023-10-24
Primary completion: 2025-10-24
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.